Psoriasis drug showdown: which pill works better?
NCT ID NCT07581418
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two oral medications, methotrexate and tofacitinib, for treating chronic plaque psoriasis. About 88 adults with moderate to severe psoriasis who haven't improved with topical treatments will be randomly assigned to one of the drugs and followed for six months. Researchers will measure skin clearing and side effects to see which option is more effective and safer.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC PLAQUE PSORIASIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a single cream tackle both skin and nail psoriasis?
- Psoriasis Drug's skin gene secrets revealed in small trial
- New hope for nail psoriasis: tildrakizumab shows promise in trial
- New drug bimekizumab shows promise for psoriasis in early trial
- New psoriasis drug shows promise in chinese trial
- Psoriasis drug showdown: which works better?